Speaker

Nadia Haque, ACA

EXECUTIVE DIRECTOR, RESEARCH TECHNOLOGIES, PHARMA PARTNERING, GENENTECH
South San Francisco, California, United States
Nadia Haque PhD is Executive Director, Research Technologies, Pharma Partnering at Genentech and Roche. In this role, Nadia works closely with Genentech's Research and Early Development organization to identify transformative science across the globe and set up partnerships to enable discovery programs with the goal of developing medicines which impact patients’ lives.

Previously Nadia was Sr. Director in Digital and Personalized Healthcare Partnering focused on real world data and advanced analytics. She also spent a couple of years in Global Alliance & Asset Management where she successfully managed several of Roche’s international partnerships across different therapeutic areas in the US, China and Japan.

Prior to joining Pharma Partnering, Nadia held roles of increasing responsibility in R&D in Oncology Biomarker Development (OBD) and Non-clinical study operations. Before coming to Genentech in 2008, Nadia worked as a Scientist in various biotech companies including Renovis and Geron. Nadia holds a PhD in Neural Transplantation from Cambridge University, UK and earned a Master of Science in Biotechnology from Imperial College, London. She did her Postdoctoral Fellowship in the department of Neurology and Neurosurgery at Harvard Medical School as a Fulbright Scholar.
Speaking In
12:00 PM - 12:15 PM
Tuesday, June 6
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most…
Session Room 104B